NDC Compounded Drug 71506-043-01 Lidocaine Hydrochloride

Injection Intravenous

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Lidocaine Hydrochloride
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 71506-043
NDC Package Code 71506-043-01
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 71506004301
Package Description 1 mL in 1 SYRINGE
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Lidocaine Hydrochloride
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Lidocaine Hydrochloride
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Lidocaine Hydrochloride
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 71506
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Fresenius Kabi Compounding Llc Dba Fagron Sterile Services
Substance Name Lidocaine Hydrochloride
Active Ingredients Information 10 mg/1 mL
Reporting Period 2023-1

NDC Crossover Products Matching Lidocaine Hydrochloride

NDC crossover of Lidocaine Hydrochloride with NDC 71506-043 a human compounded drug with other similar products matching the same substance name (Lidocaine Hydrochloride) and the same administration route (intravenous) or dosage form (injection).

Frequently Asked Questions

What is the NDC number assigned to Lidocaine Hydrochloride?

Lidocaine Hydrochloride was assigned by its manufacturer with NDC product code 71506-043. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Lidocaine Hydrochloride?

The NDC package code 71506-043-01 was assigned to a 1 mL in 1 SYRINGE of lidocaine hydrochloride administered intravenous via injection.

Who manufactures this product?

Lidocaine Hydrochloride is manufactured by an outsourced facility and labeled by Fresenius Kabi Compounding Llc Dba Fagron Sterile Services. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by The Ritedose Corporation, Pine Pharmaceuticals LLC, QuVa Pharma, Inc., Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories and Fresenius Kabi Compounding LLC DBA Fagron Sterile Services with NDC product codes 65302-526-10, 65302-526-10, 65302-526-10, 69194-917-01, 69194-917-01, 69194-919-01, 70092-479-03, 71266-9090-1, 71266-9090-1, 71266-9090-1, 71266-9090-1, 71266-9090-2, 71266-9090-2, 71266-9090-9, 71266-9090-9, 71266-9090-9, 71266-9090-9, 71266-9091-1, 71266-9091-1, 71266-9091-1, 71266-9091-1, 71266-9100-2, 71266-9100-2, 71266-9100-2, 71266-9100-3, 71266-9100-3, 71266-9100-3, 71266-9100-3, 71506-041-05 and 71506-041-05.